Literature DB >> 2822590

Diffusion and adoption of CDC guidelines for the prevention and control of nosocomial infections in US hospitals.

D D Celentano1, L L Morlock, F E Malitz.   

Abstract

Since 1981, the Centers for Disease Control (CDC) has been publishing Guidelines for the Prevention and Control of Nosocomial Infections as a useful reference tool in infection control. The extent to which practices recommended by CDC to reduce hospital-acquired infections have been successfully diffused and adopted were evaluated in a stratified random sample of 445 US hospitals that were sent a questionnaire in 1985. The data suggest that over 84% of infection control practitioner respondents (78% response rate) are aware of each guideline, although small hospitals (less than 50 beds) are least likely to be aware of the guidelines or to have reviewed them thoroughly. Adoption of the recommendations remains far from universal, ranging from 23% to 75% for 16 specific recommendations investigated. Smaller hospitals were significantly less likely than large hospitals to have adopted each suggested policy. Recommendations that carried Category I rankings were more likely to be adopted, as were those procedures that had cost-savings implications.

Entities:  

Mesh:

Year:  1987        PMID: 2822590     DOI: 10.1017/s0195941700066595

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  3 in total

1.  Attitudes toward practice guidelines among intensive care unit personnel: a cross-sectional anonymous survey.

Authors:  Dave Quiros; Susan Lin; Elaine L Larson
Journal:  Heart Lung       Date:  2007 Jul-Aug       Impact factor: 2.210

2.  Infection control practices in intensive care units of 14 European countries. The EURO.NIS Study Group.

Authors:  M L Moro; O B Jepsen
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

3.  Impact of Guidelines on the Diffusion of Medical Technology: A Case Study of Cardiac Resynchronization Therapy in the UK.

Authors:  Rucha Vadia; Tom Stargardt
Journal:  Appl Health Econ Health Policy       Date:  2020-09-24       Impact factor: 2.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.